| Patent | Date |
|---|
Combination therapy using antibody to human Siglec-9 and antibody to human NKG2A for treating cancer
Grant 11,447,545 - Cornen , et al. September 20, 2 | 2022-09-20 |
Pharmaceutical Formulations And Dosage Regimens For Multi-specific Binding Proteins That Bind Her2, Nkg2d, And Cd16 For Cancer Treatment
App 20220195065 - Chang; Gregory P. ; et al. | 2022-06-23 |
Heterodimeric Fc-fused Proteins
App 20220119533 - CHEUNG; Ann F. ; et al. | 2022-04-21 |
Multi-specific Binding Proteins That Bind Bcma, Nkg2d And Cd16, And Methods Of Use
App 20220089760 - Bigelow; Mitchell ; et al. | 2022-03-24 |
Treatment of cancers using anti-NKG2A agents
Grant 11,225,519 - Andre , et al. January 18, 2 | 2022-01-18 |
Siglec Neutralizing Antibodies
App 20210363249 - CORNEN; STEPHANIE ; et al. | 2021-11-25 |
Protein Binding Nkg2d, Cd16 And A Fibroblast Activation Protein
App 20210363261 - Chang; Gregory P. ; et al. | 2021-11-25 |
Multi-specific Binding Proteins That Bind Bcma, Nkg2d And Cd16, And Methods Of Use
App 20210317223 - Bigelow; Mitchell ; et al. | 2021-10-14 |
Proteins Binding Nkg2d, Cd16, And Egfr, Ccr4, Or Pd-l1
App 20210261668 - Chang; Gregory P. ; et al. | 2021-08-26 |
Siglec-10 antibodies
Grant 11,083,785 - Cornen , et al. August 10, 2 | 2021-08-10 |
Siglec neutralizing antibodies
Grant 11,078,274 - Cornen , et al. August 3, 2 | 2021-08-03 |
Proteins Binding Nkg2d, Cd16 And An Antigen Associated With Tumors, Mdscs And/or Tams
App 20210221894 - Bigelow; Mitchell ; et al. | 2021-07-22 |
Multi-specific Binding Proteins That Bind Her2, Nkg2d, And Cd16, And Methods Of Use
App 20210198369 - Chang; Gregory P. ; et al. | 2021-07-01 |
Neutralization Of Inhibitory Pathways In Lymphocytes
App 20210122821 - ANDRE; PASCALE ; et al. | 2021-04-29 |
Combination Therapy Of Cancer Involving Multi-specific Binding Proteins That Activate Natural Killer Cells
App 20210079102 - Chang; Gregory P. ; et al. | 2021-03-18 |
Neutralization of inhibitory pathways in lymphocytes
Grant 10,870,700 - Andre , et al. December 22, 2 | 2020-12-22 |
Combination Therapy Using Antibody To Human Siglec-9 And Antibody To Human Nkg2a For Treating Cancer
App 20200369764 - CORNEN; STEPHANIE ; et al. | 2020-11-26 |
Siglec-9-neutralizing Antibodies
App 20200369765 - CORNEN; STEPHANIE ; et al. | 2020-11-26 |
Neutralization Of Inhibitory Pathways In Lymphocytes
App 20200332008 - ANDRE; PASCALE ; et al. | 2020-10-22 |
Proteins Binding Nkg2d, Cd16 And A Tumor-associated Antigen
App 20200231679 - Chang; Gregory P. ; et al. | 2020-07-23 |
Neutralization of inhibitory pathways in lymphocytes
Grant 10,711,063 - Andre , et al. | 2020-07-14 |
Proteins Binding Nkg2d, Cd16, And Egfr, Hla-e, Ccr4, Or Pd-l1
App 20200216544 - Chang; Gregory P. ; et al. | 2020-07-09 |
Treatment regimens using anti-NKG2A antibodies
Grant 10,676,523 - Andre , et al. | 2020-06-09 |
Treatment Of Cancers Using Anti-nkg2a Agents
App 20190322744 - ANDRE; PASCALE ; et al. | 2019-10-24 |
Treatment of cancers using anti-NKG2A agents
Grant 10,329,348 - Andre , et al. | 2019-06-25 |
Siglec Neutralizing Antibodies
App 20190085077 - CORNEN; STEPHANIE ; et al. | 2019-03-21 |
Neutralization Of Inhibitory Pathways In Lymphocytes
App 20190031755 - ANDRE; PASCALE ; et al. | 2019-01-31 |
Siglec-10 Antibodies
App 20180344829 - CORNEN; STEPHANIE ; et al. | 2018-12-06 |
Treatment Of Cancers Using Anti-nkg2a Agents
App 20170313773 - ANDRE; PASCALE ; et al. | 2017-11-02 |
Cross Reactive Siglec Antibodies
App 20170306014 - CORNEN; STEPHANIE ; et al. | 2017-10-26 |
Neutralization Of Inhibitory Pathways In Lymphocytes
App 20170291947 - ANDRE; PASCALE ; et al. | 2017-10-12 |
Molecular clone of a P58 receptor protein and uses thereof
Grant 5,808,028 - Long , et al. September 15, 1 | 1998-09-15 |
| 